XML 16 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
OPERATING ACTIVITIES    
Net income including non-controlling interests $ 7,680 $ 6,151
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation and amortization 2,091 1,807
Provision for doubtful accounts 1,089 990
Equity-based awards compensation expense 1,221 990
Loss (gain) on sale of fixed assets (19) 17
Excess tax benefit from exercise of equity-based awards (323) (271)
Deferred income tax 2,709 565
Other 0 35
Changes in operating assets and liabilities:    
Increase in patient accounts receivable (2,185) (2,185)
Decrease in accounts receivable - other 43 125
Increase (decrease) in other assets (2,282) 106
Increase (decrease) in accounts payable and accrued expenses 4,322 (5,976)
Increase in other liabilities 365 665
Net cash provided by operating activities 14,711 3,019
INVESTING ACTIVITIES    
Purchase of fixed assets (1,738) (1,419)
Purchase of businesses, net of cash acquired (12,899) (6,445)
Acquisitions of non-controlling interests (1,524) (359)
Proceeds on sale of fixed assets, net 42 8
Net cash used in investing activities (16,119) (8,215)
FINANCING ACTIVITIES    
Distributions to non-controlling interests (including redeemable non-controlling interests) (1,613) (1,589)
Cash dividends to shareholders - funded (2,125) 0
Proceeds from revolving line of credit 49,000 34,000
Payments on revolving line of credit (40,500) (27,000)
Principal payments on notes payable (250) (200)
Tax benefit from equity-based awards 323 271
Other 1 0
Net cash provided by financing activities 4,836 5,482
Net increase in cash and cash equivalents 3,428 286
Cash and cash equivalents - beginning of period 15,778 14,271
Cash and cash equivalents - end of period 19,206 14,557
Cash paid during the period for:    
Income taxes 2,265 1,275
Interest 248 235
Non-cash investing and financing transactions during the period:    
Purchase of business - seller financing portion 500 500
Acquisition of noncontrolling interest - seller financing portion $ 514 $ 0